BRPI0606783A2 - derivados de imidazol - Google Patents

derivados de imidazol

Info

Publication number
BRPI0606783A2
BRPI0606783A2 BRPI0606783-2A BRPI0606783A BRPI0606783A2 BR PI0606783 A2 BRPI0606783 A2 BR PI0606783A2 BR PI0606783 A BRPI0606783 A BR PI0606783A BR PI0606783 A2 BRPI0606783 A2 BR PI0606783A2
Authority
BR
Brazil
Prior art keywords
imidazole derivatives
compounds
mgiur
report
prevention
Prior art date
Application number
BRPI0606783-2A
Other languages
English (en)
Inventor
Silvia Gatti Mcarthur
Erwin Goetschi
Juergen Wichmann
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0606783A2 publication Critical patent/BRPI0606783A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Psychology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

DERIVADOS DE IMIDAZOL. A invenção refere-se a compostos de fórmula I: em que R^ 1^, R^ 2^, R^ 3^ e X são como definido no relatório, métodos de preparação dos mesmos e usos dos mesmos, compostos estes que são úteis para prevenção e tratamento de distúrbios mediados por receptor de mGIuR 2.
BRPI0606783-2A 2005-02-03 2006-01-30 derivados de imidazol BRPI0606783A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05100751 2005-02-03
PCT/EP2006/000762 WO2006082002A1 (en) 2005-02-03 2006-01-30 Imidazole derivatives

Publications (1)

Publication Number Publication Date
BRPI0606783A2 true BRPI0606783A2 (pt) 2009-07-14

Family

ID=36180610

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0606783-2A BRPI0606783A2 (pt) 2005-02-03 2006-01-30 derivados de imidazol

Country Status (11)

Country Link
US (1) US20060173048A1 (pt)
EP (1) EP1846389A1 (pt)
JP (1) JP2008528649A (pt)
KR (1) KR20070107093A (pt)
CN (1) CN101155796A (pt)
AU (1) AU2006210048A1 (pt)
BR (1) BRPI0606783A2 (pt)
CA (1) CA2596854A1 (pt)
IL (1) IL184559A0 (pt)
MX (1) MX2007009108A (pt)
WO (1) WO2006082002A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8012986B2 (en) 2007-04-02 2011-09-06 Hoffmann-La Roche Inc. Pyridine and pyrimidine derivatives as MGLUR2 antagonists
WO2009097414A1 (en) * 2008-01-29 2009-08-06 Vanda Pharmaceuticals, Inc. Use of imidazolylalkyl-pyridines for the treatment of addictive disorders
WO2012084678A1 (en) 2010-12-23 2012-06-28 Syngenta Participations Ag Novel imidazoles useful as plant fungicides
EP3181552B1 (en) * 2014-08-13 2020-10-21 Nippon Soda Co., Ltd. Diaryl imidazole compound and pest control agent
US11976045B1 (en) 2023-10-23 2024-05-07 King Faisal University 3-(4,5-bis(4-bromophenyl)-2-(4-chlorophenyl)-1H-imidazol-1-yl)propanoic acid as an antimicrobial compound
US11912665B1 (en) 2023-10-25 2024-02-27 King Faisal University 4-(2,4,5-tris(4-chlorophenyl)-1H-imidazol-1-yl)butanoic acid as an antimicrobial compound

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0889887A4 (en) * 1996-03-25 2003-06-11 Smithkline Beecham Corp TREATMENT OF CENTRAL NERVOUS SYSTEM INJURIES
US20040053943A1 (en) * 2000-11-20 2004-03-18 Adams Jerry L. Novel compounds
US7091222B2 (en) * 2003-07-03 2006-08-15 Hoffmann-La Roche Inc. Imidazole derivatives

Also Published As

Publication number Publication date
IL184559A0 (en) 2007-10-31
US20060173048A1 (en) 2006-08-03
JP2008528649A (ja) 2008-07-31
EP1846389A1 (en) 2007-10-24
WO2006082002A1 (en) 2006-08-10
CA2596854A1 (en) 2006-08-10
CN101155796A (zh) 2008-04-02
AU2006210048A1 (en) 2006-08-10
MX2007009108A (es) 2007-09-06
KR20070107093A (ko) 2007-11-06

Similar Documents

Publication Publication Date Title
NO20074275L (no) 2- (4-okso-4H-kinazolin-3-yl) acetamider og deres anvendelse som Vasopressin-V3-antagonister
NO20083427L (no) Cystoksiske midler omfattende nye tomaymycinderivater og deres terapeutiske anvendelse
EA201100299A1 (ru) Органические соединения
WO2007140439A3 (en) Compounds as cannabinoid receptor ligands and uses thereof
NO20084007L (no) Spirokondenserte piperidiner som modulatorer av muskarinreseptorer
WO2009046841A8 (de) Piperidin- und piperazinderivate zur behandlung von tumoren
WO2007138282A3 (en) Bi-aryl or aryl-heteroaryl substituted indoles
ECSP088623A (es) Derivados de azepinoindol como agentes farmacéuticos
WO2008040649A3 (en) Pyrazine-2-carboxamide derivatives as cb2 receptor modulators
EA201100311A1 (ru) Амидные производные гетероарилов и их применение в качестве активаторов глюкокиназы
ATE544761T1 (de) Pyrimidinderivate und zusammensetzungen als c-kit-und pdgfr-kinasehemmer
MX2010001486A (es) Derivados de tetrahidropiridin carboxamida como antagonistas de trpvl.
MA32544B1 (fr) Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
WO2008045371A3 (en) N-substituted-azacyclylamines as histamine-3 antagonists
MX2008013196A (es) 5-amido-2-carboxiamida-indoles.
MX2010008713A (es) Derivados de 5,6-bisaril-2-piridina-carboxamida, su preparacion y su aplicacion en terapeutica como antagonistas de los receptores de la urotensina ii.
TW200942535A (en) Novel compounds as cannabinoid receptor ligands
JO2682B1 (en) Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof
ATE430744T1 (de) Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren
BRPI0518203A2 (pt) mÉtodos para preparaÇço de compostos indazol
ATE542795T1 (de) Benzylpiperazinderivate als motilin- rezeptorantagonisten
NO20084301L (no) Tetrahydronaftalenderivater, fremgangsmate for deres fremstilling og anvendelse derav som anti-inflammatoriske midler
WO2009055629A3 (en) Cyclohexeneamide derivatives and their use as trpv1 antagonist
WO2008008700A3 (en) Substituted cyclopentane derivatives as therapeutic agents
BRPI0606964A2 (pt) pirrolidinas e piperidinas derivadas do acetileno para uso como antagonistas de mglur5

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]